SNES

ContraPest® Deploying at Waste Water Treatment Facilities

Retrieved on: 
Monday, September 11, 2023
Poison, Invention, ContraPest, SNES, Male, EPA, Rat, SenesTech, Elevate, Water supply, Female, Tunnel

PHOENIX, Sept. 11, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that ContraPest is being deployed into a new vertical, waste water treatment facilities, with deployments in both Washington and California.

Key Points: 
  • PHOENIX, Sept. 11, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, today announced that ContraPest is being deployed into a new vertical, waste water treatment facilities, with deployments in both Washington and California.
  • Waste water management presents a unique challenge in controlling rat infestations.
  • Poisons can not be introduced into the water supply, and ground-based stations may not be appropriate for much of the facilities.
  • Waste water treatment deployment has very specific challenges, and we are able to develop and share deployment protocols utilized by other, similar customers," said Joel Fruendt, SenesTech's President and Chief Executive Officer.

SenesTech Announces Closing of Warrant Exercise for $2.1 Million in Gross Proceeds

Retrieved on: 
Tuesday, August 29, 2023
Exercise, Male, Rat, SenesTech, ContraPest, Sale, EPA, Invention, SNES, Female, Security (finance), Trapping

PHOENIX, Aug. 29, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced today the closing of its previously announced exercise of certain existing warrants to purchase 2,934,575 shares of its common stock at a reduced exercise price of $0.7202 per share. In addition, the Company issued new warrants, as described below. The aggregate gross proceeds from the exercise of the existing warrants were approximately $2.1 million, before deducting placement agent fees and other offering expenses payable by the Company.

Key Points: 
  • The aggregate gross proceeds from the exercise of the existing warrants were approximately $2.1 million, before deducting placement agent fees and other offering expenses payable by the Company.
  • As consideration for the exercise of such existing warrants for cash, the Company issued new unregistered warrants to purchase shares of common stock in a private placement.
  • The new warrants offered have not been registered under the Securities Act of 1933, as amended, or under applicable state securities laws.
  • The new design, along with an enhanced formulation, ensures improved performance in the field, providing superior results.

SenesTech Announces Second Quarter 2023 Financial Results

Retrieved on: 
Thursday, August 10, 2023
Male, Rat, Poultry, Marketing, SenesTech, ContraPest, GAAP, Government, Grain, Interest, Rodenticide, EPA, EBITDA, Traction, Investment, Risk, Growth, Invention, SNES, Female, Agriculture, Pharmaceutical industry

PHOENIX, Aug. 10, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced financial results for the second quarter of 2023 for the period ended June 30, 2023.

Key Points: 
  • PHOENIX, Aug. 10, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA-registered contraceptive for male and female rats, ContraPest®, today announced financial results for the second quarter of 2023 for the period ended June 30, 2023.
  • Sales growth during the second quarter was led by significant increases in the government vertical driven by deployments in California and New England, as well as continued traction within zoos and animal sanctuaries.
  • With 126% sales growth during the month of July 2023, I believe we are well positioned for a strong second half of the year," Fruendt concluded.
  • Net loss during Q2 2023 was $2.0 million, compared with a net loss of $2.6 million for Q2 2022.

SenesTech to Report Second Quarter 2023 Financial Results on Thursday, August 10, 2023

Retrieved on: 
Thursday, August 3, 2023
Conference call, SNES, SenesTech, Conference, Financial result

PHOENIX, Aug. 3, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on Thursday, August 10, 2023. The Company has scheduled a conference call that same day, Thursday, August 10, 2023, at 5:00 pm ET, to review the results.

Key Points: 
  • Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET
    PHOENIX, Aug. 3, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its second quarter 2023, ended June 30, 2023, after the market close on Thursday, August 10, 2023.
  • The Company has scheduled a conference call that same day, Thursday, August 10, 2023, at 5:00 pm ET, to review the results.
  • Replay: A teleconference replay of the call will be available for seven days at (877) 344-7529 or (412) 317-0088, replay access code 8370307.
  • A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ for 90 days.

SenesTech Launches Isolate Bait System™ for Contrapest®

Retrieved on: 
Monday, July 24, 2023
Male, Rat, Maintenance, SenesTech, Isolate, ContraPest, EPA, Invention, SNES, Female, Trapping

PHOENIX, July 24, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced the launch of a new delivery system for ContraPest®, the Isolate Bait System™. This system also incorporates an enhanced formulation of ContraPest that is expected to provide improved performance of the fertility control bait in the field. The Isolate is paired with a new bait station that is more efficient and economical.

Key Points: 
  • This system also incorporates an enhanced formulation of ContraPest that is expected to provide improved performance of the fertility control bait in the field.
  • The Isolate is paired with a new bait station that is more efficient and economical.
  • Product Overview: The Isolate Bait System is specifically designed based on customer demands for a more efficient and easier-to-use bait system.
  • "The design of the Isolate Bait System comes directly from customer requests, who wanted to maintain the efficacy of ContraPest, but make the deployment and servicing quicker and easier.

SenesTech Announces Distribution Agreement and Initial Order for ContraPest® in Maldives

Retrieved on: 
Monday, June 5, 2023
Male, Rat, Partnership, SenesTech, ContraPest, Female, EPA, Invention, SNES, Environment, Safety, Agriculture

PHOENIX, June 5, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), (www.senestech.com) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced entry into a Distribution Agreement with Pesterminators Pvt Ltd of Maldives ("Pesterminators") for the deployment of ContraPest® into Maldives. As Pesterminators is part of an multinational pest control organization, the potential expansion of the agreement throughout the region is contemplated in the agreement.

Key Points: 
  • PHOENIX, June 5, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced entry into a Distribution Agreement with Pesterminators Pvt Ltd of Maldives ("Pesterminators") for the deployment of ContraPest® into Maldives.
  • As Pesterminators is part of an multinational pest control organization, the potential expansion of the agreement throughout the region is contemplated in the agreement.
  • "Pesterminators is a leading provider of pest management solutions, committed to providing the best possible service while maintaining a safe and sustainable environment.
  • "This collaboration with SenesTech opens up exciting possibilities beyond the Maldives.

SenesTech Announces Development and Distribution Agreement for ContraPest® in South Africa

Retrieved on: 
Thursday, June 1, 2023
NSPCA, Male, Rat, Pest control, Marketing, SenesTech, Public, ContraPest, IPM, PES, EPA, National Council, Distribution, Invention, SNES, Institute for Environmental Solutions, Female, Pharmaceutical industry, African

PHOENIX, June 1, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced entry into a Development and Distribution Agreement with Pathogens and Environmental Solutions (PES) of South Africa for the commercialization of ContraPest® into South Africa.

Key Points: 
  • PHOENIX, June 1, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, announced entry into a Development and Distribution Agreement with Pathogens and Environmental Solutions (PES) of South Africa for the commercialization of ContraPest® into South Africa.
  • Under the agreement, PES will be responsible for seeking regulatory registration, and all marketing and sales of ContraPest into South Africa.
  • "South Africa is a leading sub-Saharan economy with an active pest control industry focused on the agricultural and public health applications of pest control.
  • "Once regulatory approval is achieved, we look forward to offering our customers this unique rodent control alternative, complementing our current rodent control offering in South Africa and our other African partners."

ContraPest® Deployment Expands to Grain Storage and Transport

Retrieved on: 
Monday, May 8, 2023
Invention, Grain, ContraPest, SNES, Male, EPA, IPM, Rat, Growth, SenesTech, News, Female, Agriculture

"20% of the world's stored food supply is lost to rats' consumption and contamination, with estimates over 30% when specifically referring to grain storage and transport.

Key Points: 
  • "20% of the world's stored food supply is lost to rats' consumption and contamination, with estimates over 30% when specifically referring to grain storage and transport.
  • It is a particularly difficult pest control challenge, as there is a constant influx of new rats when grain is loaded or delivered, and the potential use of lethal tools is limited.
  • This is one of the pest control challenges that led the Company to develop ContraPest," said Joel Fruendt, SenesTech's President and CEO.
  • If this follows the success we have seen in other customer segments, this initial deployment represents a significant account growth potential."

SenesTech to Report First Quarter 2023 Financial Results on Thursday, May 11, 2023

Retrieved on: 
Thursday, May 4, 2023
Conference call, SNES, SenesTech, Conference, Financial result

PHOENIX, May 4, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023. The Company has scheduled a conference call that same day, Thursday, May 11, 2023, at 5:00 pm ET, to review the results.

Key Points: 
  • Financial results to be released after market close; Conference call to be conducted at 5:00 pm ET
    PHOENIX, May 4, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES) will report financial results for its first quarter 2023, ended March 31, 2023, after the market close on Thursday, May 11, 2023.
  • The Company has scheduled a conference call that same day, Thursday, May 11, 2023, at 5:00 pm ET, to review the results.
  • Replay: A teleconference replay of the call will be available for seven days at (877) 344-7529 or (412) 317-0088, replay access code 7883276.
  • A webcast replay will be available in the Investor Relations section of the Company's website at http://senestech.investorroom.com/ for 90 days.

SenesTech Presents ContraPest® At PEAK 2023 Poultry Show

Retrieved on: 
Monday, April 24, 2023
Male, Rat, Poultry, SenesTech, ContraPest, Minneapolis, PEAK, PMP, Minneapolis Convention Center, MPF, EPA, Infestation, Elevate, Invention, SNES, Female, Renewable energy

PHOENIX, April 24, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, recently concluded participation at PEAK 2023, the largest trade show in the United States focused on poultry.

Key Points: 
  • PHOENIX, April 24, 2023 /PRNewswire/ -- SenesTech, Inc. (NASDAQ: SNES, "SenesTech" or the "Company"), ( www.senestech.com ) the rodent fertility control experts and inventors of the only EPA registered contraceptive for male and female rats, ContraPest®, recently concluded participation at PEAK 2023, the largest trade show in the United States focused on poultry.
  • The Midwest Poultry Federation (MPF) was founded in 1971 as a 501(c)6 nonprofit organization and held its first convention in Minneapolis in 1972.
  • "The poultry market is a vast opportunity for us, with an addressable market size of close to $200 million.
  • Furthermore, in one deployment, the customer reported more than $600,000 saved in labor, loss, and damage, with a modest $5,000 investment in ContraPest," concluded Mr. Fruendt.